Daily Newsletter 4:5:18

Gooooooooood morning y’all..

Happy blessed Thursday y’all. Welcome back to the trading blog. Today, the pre-market is hot and super spicy on the bullish side. That sense of understanding, feeling, and knowing the market comes with a heavy price of being part of it for the past few years. For those who are expert and been trading for a while, knows the market condition determines which way the stock will go, regardless of its great news or awesome chart pattern.

I am super excited, starving, and bullish for today’s trading session. Will be looking for a position if the stock market can reveals itself with low risk and high reward technical view. Looking for good press release (reasoning) plus bottom out and above or far away from major chart indictors.

Here is today’s iTwitsTrades Watchlist:

News:

  • $CASI (announces receipt of a letter from the Center for Drug Evaluation (CDE) (group within the China FDA in charge of technical review) indicating that EVOMELA® (melphalan) for injection has been scheduled for review by the Expert Advisory Anti-Tumor (Oncology) Drugs Committee (the “Advisory Committee”), which is scheduled to take place between April 25-26, 2018 (the “Advisory Committee Meeting”)
  • $ARDM ( today announced the completed formal validation by the European Medicines Agency (EMA) of the Marketing Authorisation Application (MAA) for Linhaliq for the treatment of non-cystic fibrosis bronchiectasis (NCFBE) patients with chronic lung infections with Pseudomonas aeruginosa (P. aeruginosa). The completion of the MAA validation is commensurate with the start date of the review procedure on March 29, 2018.)
  • $EOLS (Evolus Phase III European – Canadian Head-to-Head Trial of prabotulinumtoxinA Compared to Botox® Meets Primary Endpoint)

Chart Patterns:

$SLS Possible mid-candle breakout for possible another bullish day. Since the bears took their profits, now the stock is trying to find its support.

Today’s Market Briefing:

Futures were higher this morning after what seemed like an unlikely rally in Wednesday’s session. The Dow was down as much as 510 points and the other major averages were lower as well, only to see all those deficits wiped out in an impressive afternoon comeback. (CNBC)Facebook (FB) upped its estimate of how many users may have had their personal information improperly shared with political consulting firm Cambridge Analytica to 87 million from the prior 50 million. CEO Mark Zuckerberg also said he’s “responsible for what happened.” (CNBC)

Today’s Pre-Market Gappers:

Today’s Pre-market PR News Scan:

Yesterday’s Overview market:

Yesterday’s Top Gainer and loser list of stocks:

Disclaimer:
Am a mid-class hard working person, with possible winning opinions on the stock market? I tweet, post, and discuss securities, which are nt to be used for personal investment. Thank you for stopping by. Please subscribe, follow, and stay up to date with all my blogs in the future. Below is the link(s) to all my social media:
No Recommendations or Advice Provided – Contact Your Own Investment, Tax or Legal Advisor
https://itwitstrades.wordpress.com, including Ramy Dobia, hereinafter referred to as (“iTwitsTrade”) or (“the service”) provides general information only. It is not meant to be a recommendation to buy or to sell securities nor an offer to buy or sell securities. iTwitsTrade is not registered as a securities broker-dealer or as an investment adviser either with the U.S. Securities and Exchange Commission or with any state securities regulatory authority and do not attempt or intend to influence the purchase or sale of any security.
iTwitsTrade is neither licensed nor qualified to provide investment advice. As such, iTwitsTrade accepts no liability whatsoever for any direct or consequential loss arising from any use of information from the Service. No information from iTwitsTrade is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security, or fund. iTwitsTrade recommends that persons desiring to trade or invest in securities do so cautiously and in consultation with their qualified financial, legal, and tax advisors.
I cannot and do not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. You bear responsibility for your own investment research and decisions and should seek the advice of a qualified securities professional before making any investment. Before selling or buying any stock or other investment you should consult with a qualified broker or another financial professional to verify pricing information.
iTwitsTrade reserves the right, for its officers, directors, shareholders, and agents as well as itself, to buy and/or sell securities mentioned on this web site. We are active traders and may — but need not –buy or sell any of these securities at any time and without notice. Our buying and selling of any of these securities may influence their market prices.
Past Performance is not indicative of future results.
Many microcap companies do not file reports with the SEC, making it difficult to get the facts about such a company’s management, products, services, and finances.
Never depend solely on the information contained in an Internet publication. The risk of fraudulent information exists with many Internet sites.
This site contains information concerning iTwitsTrade and its affiliates that may be useful to iTwitstrade’s customers, and readers as well as members of the general public. However, by using this site you are accepting all of the terms of this disclaimer notice, including exclusions and limitations of liability. If you do not agree with anything in this notice, you should not use this website.
While reasonable efforts are made to ensure that the contents of this site are accurate, this site and its contents are provided on an “as is,” “as available” basis, without warranties of any kind, including any warranty that the site will be kept up to date, be true and not misleading, or that the site will always (or ever) be available for use. iTwitsTrade and its affiliates disclaim all warranties, express or implied, with respect to the site and its contents, including, without limitation, any warranties of accuracy, completeness, timeliness, non-infringement, title, merchantability, or fitness for a particular purpose. Because some jurisdictions do not permit the exclusion of certain warranties, these exclusions may not apply to you.
iTwitsTrade does not warrant that the servers that make this site available will be errors, virus-, worm-, or bug-free and you accept that it is your responsibility to make adequate provision for protection against such threats.
In no event will iTwitsTrade or its affiliates be liable for any incidental, indirect, consequential, or special damages of any kind, or any damages whatsoever, including, without limitation, those resulting from loss of profits, contracts, goodwill, data, information, income, anticipated savings, or business relationships, whether or not iTwitsTrade or its affiliates have been advised of the possibility of such damage, arising out of or in connection with the use of this site or its contents or any other sites linked to this site.

All information are gathered and credited to:
CNBC
FinViz
Yahoo

 

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

Powered by WordPress.com.

Up ↑

%d bloggers like this: